Healthcare ❯Pharmaceuticals

Drug Approval

FDA Clinical Trials FDA Regulations Alzheimer's Disease Regulatory Agencies China FDA Processes NHS Policies Weight Management Imdelltra Antipsychotic Medications Eli Lilly Nasal Spray Esketamine FDA Drug Approval Xolair Cardiovascular Health Bristol Myers Squibb FDA Approval Blood Disorder Treatment

FDA Approves First Standalone Nasal Spray for Treatment-Resistant Depression

FDA Approves First Nasal Spray for Treatment-Resistant Depression

FDA Approves First New Schizophrenia Drug in Decades

FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Biogen Raises 2024 Profit Forecast Following Strong Q2 Earnings

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

Geron Shares Soar After FDA Approves New Blood Disorder Drug

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market

FDA Approves Xolair for Severe Food Allergies